Cobamide Structure Depends on Both Lower Ligand Availability and CobT Substrate Specificity  by Crofts, Terence S. et al.
Chemistry & Biology
ArticleCobamide Structure Depends
on Both Lower Ligand Availability
and CobT Substrate Specificity
Terence S. Crofts,1 Erica C. Seth,1 Amrita B. Hazra,1 and Michiko E. Taga1,*
1Department of Plant and Microbial Biology, University of California, Berkeley, Berkeley, CA 94720, USA
*Correspondence: taga@berkeley.edu
http://dx.doi.org/10.1016/j.chembiol.2013.08.006SUMMARY
Cobamides are members of the vitamin B12 family of
cofactors that function in a variety of metabolic pro-
cesses and are synthesized only by prokaryotes.
Cobamides produced by different organisms vary
in the structure of the lower axial ligand. Here we
explore the molecular factors that control specificity
in the incorporation of lower ligand bases into coba-
mides. We find that the cobT gene product, which
activates lower ligand bases for attachment, limits
the range of lower ligand bases that can be incorpo-
rated by bacteria. Furthermore, we demonstrate that
the substrate specificity of CobT can be predictably
altered by changing two active site residues. These
results demonstrate that sequence variations in
cobT homologs contribute to cobamide structural
diversity. This analysis could open new routes to en-
gineering specific cobamide production and under-
standing cobamide-dependent processes.
INTRODUCTION
Many environmentally and industrially important microbial pro-
cesses such as methanogenesis, acetogenesis, and reductive
dechlorination are dependent on corrinoids, a class of cofactors
produced solely by a subset of prokaryotes (Roth et al., 1996;
Banerjee and Ragsdale, 2003). Corrinoids are modified tetrapyr-
roles that contain a centrally bound cobalt atom (Roth et al.,
1996). Corrinoids that contain an upper and lower ligand are
termed cobamides. Cobalamin 1, also known as vitamin B12
(Figure 1A), is the best-studied cobamide, and is an essential mi-
cronutrient formost animals including humans (Roth et al., 1996).
Whereas humans are thought to have a specific requirement for
cobalamin 1, 16 different cobamides with structural variability in
the lower ligand (Figure 1B) have been described (Renz, 1999).
Most microbes described to date produce only one to two
different cobamides when grown in pure culture (Kra¨utler et al.,
1988; Stupperich et al., 1989, 1990; Keck and Renz, 2000).
Although the factors that limit the range of cobamides produced
by an organism remain unclear, previous studies have shown
that different cobamides may not be functionally equivalent as
cofactors for cobamide-dependent enzymes (Ford et al., 1955;Chemistry & Biology 20, 1265–1Barker et al., 1960a, 1960b; Chan and Escalante-Semerena,
2011; Yi et al., 2012; Mok and Taga, 2013).
The de novo biosynthesis of a cobamide requires approxi-
mately 30 gene products (Warren et al., 2002). The attachment
of the lower ligand base to the cobamide precursor GDP-cobina-
mide (GDP-Cbi 10) is the last step in cobamide biosynthesis. This
process has been studied most extensively in Salmonella enter-
ica (Roth et al., 1996). Prior to attachment, the lower ligand base
is activated by the CobT enzyme by the transfer of a phosphor-
ibose moiety from nicotinate mononucleotide or a related com-
pound to form an a-glycosidic linkage (Figure 1C) (Friedmann,
1965; Friedmann and Harris, 1965; Cameron et al., 1991; Trze-
biatowski and Escalante-Semerena, 1997). The phosphoribosy-
lated base is subsequently attached to GDP-Cbi 10 by CobS,
and the phosphate group is removed by CobC to form the
cobamide (Figure 1C) (Roth et al., 1996; Maggio-Hall and Esca-
lante-Semerena, 1999; Zayas and Escalante-Semerena, 2007).
Homologs of cobT are present in nearly all bacterial genomes
that contain the complete corrinoid biosynthesis pathway
(Rodionov et al., 2003). However, in organisms that produce
cobamides by an aerobic pathway, the cobT homolog is termed
cobU (Roth et al., 1996). Two additional cobT homologs, termed
arsA and arsB, have been described in the bacteriumSporomusa
ovata. These genes together encode a heterodimeric enzyme
responsible for the activation of phenolic lower ligand bases
(Chan and Escalante-Semerena, 2011).
In this work, we investigate the molecular factors that limit the
range of cobamides that can be produced by a single bacterial
species. Two hypotheses are tested to address this question.
First, the range of lower ligands that can be attached to form co-
bamides may be limited by the substrate specificity of the CobT
enzyme. Alternatively, the cobamides produced by an organism
may be limited solely by the availability of potential lower ligands.
Evidence in favor of the first hypothesis comes from our previous
observations of corrinoid biosynthesis in the Sinorhizobium
meliloti bluB mutant. Si. meliloti bluB is unable to synthesize
5,6-dimethylbenzimidazole (DMB, the lower ligand of cobalamin
1) and instead produces the incomplete corrinoid GDP-Cbi 10
rather than incorporating intracellular adenine (Ade) to produce
pseudo-B12 6 (adeninyl cobamide, [Ade]Cba) (Campbell et al.,
2006). Similarly, Lactobacillus reuteri does not produce cobal-
amin 1 when DMB is provided and instead produces only [Ade]
Cba 6 (Santos et al., 2007). The second hypothesis is supported
by previous studies demonstrating the ability of several bacteria
to attach a variety of exogenously provided lower ligands (Ford
et al., 1955; Perlman andBarrett, 1958; Kamikubo andMatsuura,274, October 24, 2013 ª2013 Elsevier Ltd All rights reserved 1265
Figure 1. Structures of Cobamides and Lower Ligands
(A) Structure of cobalamin. The upper ligand, R, is a methyl or 50-deoxyadenosyl group in the cofactor forms and a cyano group in the vitamin form. The lower
ligand, DMB, is indicated by the box.
(B) Structures of cobamide lower ligands. The name of each compound and the abbreviation for the corresponding cobamide are given below each structure.
(C) The lower ligand attachment pathway. The pathway for the activation and attachment of DMB to form cobalamin is shown with the names of the Sa. enterica
enzymes given. CobT catalyzes the activation of DMB by the attachment of a phosphoribose moiety derived from nicotinate mononucleotide to form a-ribazole
phosphate. The CobS and CobC enzymes catalyze the attachment of the activated base to the cobamide precursor GDP-cobinamide (GDP-Cbi 10) and
dephosphorylation of the product to form cobalamin, respectively. NaMN, nicotinic acid mononucleotide; GDP, guanosine diphosphate; GMP, guanosine
monophosphate; Pi, inorganic phosphate.
See also Figure S1.
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Hall and Escalante-Semerena, 1999). For example, Sa. enterica
produces [Ade]Cba 6 and 2-methyladenylcobamide 7 ([MeAde]
Cba), and Sp. ovata produces phenolylcobamide 8 ([Phe]Cba)
and p-cresolylcobamide 9 ([Cre]Cba) when cultured without a
lower ligand base, but both can produce benzimidazolyl coba-
mides when benzimidazole bases are provided (Stupperich
and Eisinger, 1989; Stupperich et al., 1989, 1990; Keck and
Renz, 2000; Anderson et al., 2008; Newmister et al., 2012; Mok
and Taga, 2013). In addition, X-ray crystallography studies of
Sa. enterica CobT and Sp. ovata ArsAB have demonstrated the
ability to bind a variety of lower ligand bases in their active sites
(Cheong et al., 1999, 2001, 2002; Newmister et al., 2012).
Currently, the literature as a whole does not support one hypoth-
esis over the other.
Here we test these hypotheses by examining the ability of five
phylogenetically diverse bacteria (Figure S2A available online) to
attach a variety of exogenously supplied lower ligand bases. In
addition to Si. meliloti, L. reuteri, and Sa. enterica, which are dis-
cussed above, we have investigated lower ligand attachment in
Veillonella parvula, a sequenced relative of Sp. ovata (Gronow
et al., 2010), and found that V. parvula also produces [Cre]Cba
9. Using Si. meliloti as a genetic host, we examine the role of
cobT homologs in determining the range of lower ligands that1266 Chemistry & Biology 20, 1265–1274, October 24, 2013 ª2013 Ecan be attached. We also include Dehalococcoides mccartyi in
this study, which we previously found is capable of attaching
some of the benzimidazoles investigated here, despite its
inability to synthesize a corrinoid or lower ligand base de novo
(Yi et al., 2012). Our results show that the range of lower ligands
that can be attached is controlled by both the availability of lower
ligand bases and the substrate specificity of CobT.
RESULTS
Guided Biosynthesis in Four Bacteria Shows that a
Limited Set of Lower Ligand Bases Can Be Incorporated
into Cobamides
The bacteria Si. meliloti, Sa. enterica, L. reuteri, and V. parvula
were chosen as model organisms to investigate the range of
lower ligands that can be attached to form cobamides. The
cobamides produced by Si. meliloti, Sa. enterica, and L. reuteri
have previously been identified as cobalamin 1, [Ade]Cba 6
and [MeAde]Cba 7, and [Ade]Cba 6, respectively (Keck and
Renz, 2000; Campbell et al., 2006; Santos et al., 2007). To
confirm that these cobamides are synthesized by our laboratory
strains, corrinoids were extracted and analyzed from cultures of
each organism. High-performance liquid chromatography
(HPLC) (Figure 2) and liquid chromatography-tandem masslsevier Ltd All rights reserved
Figure 2. Native Cobamides Produced by Bacteria in This Study
HPLC analysis of corrinoid extracts from cultures of the indicated bacteria is
shown. Numbers correspond to the compounds shown in Figure 1. The
identity of each numbered peak was determined by LC-MS/MS.
Figure 3. Corrinoids Produced by Guided Biosynthesis in Si. meliloti
bluB
HPLC analysis of corrinoid extracts of anSi. meliloti bluBmutant cultured in the
presence of the indicated lower ligand base is shown. Numbered peaks were
verified by LC-MS/MS.
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(data not shown) demonstrated that the expected cobamides
were present.
Sp. ovata is known to produce phenolyl cobamides due to the
activity of the ArsAB enzyme (Stupperich and Eisinger, 1989;
Stupperich et al., 1989; Chan and Escalante-Semerena, 2011).
As the genome sequence of Sp. ovata was not available at the
time, we tested whether V. parvula, a sequenced (Gronow
et al., 2010) relative of Sp. ovata, might also produce phenolyl
cobamides. HPLC analysis of corrinoid extracts from
V. parvula shows that this bacterium produces a pair of corrinoid
species that coelute with [Cre]Cba 9 extracted from Sp. ovata
cultures (Figure 2). LC-MS/MS analysis confirmed these to be
[Cre]Cba 9 by comparison of both retention time and m/z (data
not shown). Surprisingly, an additional corrinoid in the extract
from V. parvula was identified as benzimidazolylcobamide 4
([Bza]Cba) by LC-MS/MS and comparison to a standard
prepared in Sa. enterica. As such, V. parvula is the only
organism known to synthesize both phenolyl and benzimidazolyl
cobamides.
Wenext examined the ability of these organisms to incorporate
lower ligand bases provided in the culture medium, a process
known as guided biosynthesis. Each of the lower ligand bases
shown in Figure 1B (excluding 2-methyladenine) was tested for
incorporation into cobamides in each bacterium by culturing in
media containing the lower ligand base followed by corrinoid
extraction and analysis. A representative HPLC analysis of corri-
noids extracted from Si. meliloti is shown in Figure 3. An Si.
meliloti bluBmutant was used for the guided biosynthesis exper-
iment because this strain does not produce the lower ligandDMB
(Campbell et al., 2006; Taga et al., 2007). HPLC (Figure 3) and LC-
MS/MS analysis (data not shown) demonstrated that Si. meliloti
bluB attached each of the five benzimidazoles to form the corre-
sponding benzimidazolyl cobamides. However, no cobamides
were detected when Ade, Phe, or Cre was provided. LC-MS/Chemistry & Biology 20, 1265–1MS analysis revealed that the only corrinoids present in these
extracts were mono- and dicyano forms of GDP-Cbi 10, a coba-
mideprecursor lackinga lower ligand thatwepreviouslydetected
in cultures of Si. meliloti bluB (Campbell et al., 2006). The lower
ligand incorporation profiles for Sa. enterica, L. reuteri, and
V. parvula were also analyzed. The results of these experiments,
as well as previously published results for the bacterium Dc.
mccartyi (Yi et al., 2012), are summarized in Table 1. Sa. enterica
is capable of incorporating adenine in addition to each of the
five benzimidazoles, but was not capable of incorporating the
phenolic compounds, in agreement with previous findings
(Cheong et al., 2001; Chan and Escalante-Semerena, 2011).
L. reuteri could incorporate only adenine, whereas V. parvula
incorporated all of the compounds tested with the exception of
adenine (Table 1). The failure of L. reuteri to incorporate other
lower ligand bases does not appear to be due to an inability of
the molecules to enter the cell, as we detected an average
of 105 ± 2 pmol/OD600 of free DMB from the cell-pellet fraction
of three L. reuteri cultures grown with 5 mmol DMB. Together,
these results indicate that, with the exception of L. reuteri, each
bacterium can incorporate multiple lower ligands to form coba-
mides, although only Sa. enterica and V. parvula were capable
of incorporating multiple classes of lower ligands.
The Si. meliloti cobU Mutant Can Be Complemented by
Heterologous Expression of cobT Homologs
The results of the guided biosynthesis experiments suggest that
the range of lower ligands that can be attached by a bacterium
is not controlled solely by the availability of different lower
ligand bases in the environment. Next, we examined the influ-
ence of cobT on lower ligand selectivity, as cobT acts first in
the lower ligand attachment pathway (Roth et al., 1996). Specif-
ically, we tested whether expression of cobT homologs from
different bacteria could influence the range of lower ligands274, October 24, 2013 ª2013 Elsevier Ltd All rights reserved 1267
Table 1. Cobamides Produced by Guided Biosynthesis in Five Bacteria
Lower Ligand Base Provided
DMB MeBza OMeBza Bza OHBza Ade Phe Cre
Si. meliloti + + + + +   
Sa. enterica + + + + + +  
L. reuteri      +  
V. parvula + + + + +  + +
Dc. mccartyia + + + + ND ND ND ND
+, corrinoid detectable by HPLC; , corrinoid peak not detectable by HPLC or LC-MS/MS; ND, not determined. See also Figure S3 and Table S1.
aData reported by Yi et al. (2012) based on cultures supplemented with cobinamide and a lower ligand base.
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meliloti strain with a mutation in cobU (the cobT homolog in Si.
meliloti). The cobU mutant constructed for this study was un-
able to grow on LB medium without cobalamin 1 supplementa-
tion due to the cobalamin 1 requirement of the ribonucleotide
reductase enzyme (Campbell et al., 2006; Taga and Walker,
2010). This cobalamin 1 auxotrophy of the cobU strain and
the bluB cobU double mutant strain could be rescued by the
addition of cobalamin 1 to the growth medium or by expression
of the Si. meliloti cobU gene on a plasmid. To test whether cobT
homologs from other bacteria could function in Si. meliloti, cobT
homologs from Si. meliloti, Dc. mccartyi, Sa. enterica, L. reuteri,
and V. parvula were expressed on a plasmid in an Si. meliloti
bluB cobU strain in the presence of DMB. These Si. meliloti
strains are indicated hereafter by the shorthand Sm cobTDm
+,
in which two-letter abbreviations for each organism are used
(Si. meliloti, Sm; Dc. mccartyi, Dm; Sa. enterica, Se; L. reuteri,
Lr; V. parvula, Vp). All of the Si. meliloti strains expressing
cobT homologs from Dc. mccartyi, Sa. enterica, and L. reuteri
were viable and produced cobalamin 1 when DMB was pro-
vided, indicating that these cobT homologs were functional.
The ability of Sm cobTLr
+ to grow in the presence of DMB is
considered later.
An examination of the V. parvula genome revealed the pres-
ence of three different cobT homologs, Vpar_1456, Vpar_1457,
and Vpar_1602, whereas a single cobT homolog was present
in each of the other bacterial genomes we examined (except
Dc. mccartyi, which contains two cobT genes with identical
sequences) (Seshadri et al., 2005; Gronow et al., 2010). How-
ever, only one of the three cobT homologs from V. parvula,
Vpar_1602, complemented the cobalamin 1 auxotrophy of the
Si. meliloti bluB cobU strain. Vpar_1456 and Vpar_1457 are
located adjacent to one another, similar to the recently identified
Sp. ovata cobT homologs arsA and arsB (Chan and Escalante-
Semerena, 2011). To test whether Vpar_1456 and Vpar_1457,
like Sp. ovata arsA and arsB, function when expressed together,
both genes were cloned on a single plasmid. Coexpression of
these genes rescued the cobalamin 1 auxotrophy of the bluB
cobU strain in media containing DMB. Based on the function
of these genes as described below, and because the predicted
protein sequences share 46.7% and 32.6% identity with Sp.
ovata arsA and arsB, we refer to Vpar_1457 and Vpar_1456 as
arsA and arsB, respectively. The degree of relatedness among
the cobT homologs examined in this study is shown in the
pairwise identitymatrix in Table S1 and the phylogenetic analysis
in Figure S2A.1268 Chemistry & Biology 20, 1265–1274, October 24, 2013 ª2013 EExpression of cobT Homologs Alters the Lower Ligand
Attachment Profile of Si. meliloti
To test whether the expression of cobT from other bacteria could
alter the range of lower ligand bases that can be incorporated
into cobamides, guided biosynthesis assays were performed in
the Si. meliloti bluB cobU strains expressing each cobT homo-
log. A representative HPLC analysis of this assay performed
with Sm cobTSe
+ and Sm arsABVp
+ is shown in Figure 4. Sm
cobTSe
+ was found to incorporate the five benzimidazoles as
well as adenine, but was unable to attach phenol or cresol
(Figure 4A), whereas Sm arsABVp
+ could attach all of the bases
provided except adenine (Figure 4B). These results match the
results of the guided biosynthesis study for Sa. enterica and
V. parvula, respectively (Table 1), and demonstrate that these
cobT homologs are sufficient to specify the range of lower
ligands that can be attached.
In analyzing the results above, we observed differences in the
amount of incorporation of each substrate, as variable levels of
GDP-Cbi 10 were present in the corrinoid extracts (Figure 4).
We reasoned that these differences likely reflect both the overall
degree of complementation of the heterologously expressed
cobT genes aswell as differences in the ability of CobT homologs
to activate or attach each lower ligand. The amount of each coba-
mide produced by guided biosynthesis as a percentage of the
total extracted corrinoids was used as an indication of the level
of incorporation of each lower ligand (Table 2). We found that
the lower ligand bases that could be incorporated by each bacte-
rium (Table 1)mirrored the lower ligand incorporation profile ofSi.
meliloti expressing their respective cobT homologs (Table 2). An
exception to this trend was observed in L. reuteri. The inability of
L. reuteri to incorporate benzimidazoles was not transferred to
Sm cobTLr
+, because the Sm cobTLr
+ strain was able to attach
all five benzimidazoles such that GDP-Cbi 10 made up less
than half of the total corrinoids in each culture (Table 2). Although
adenine was the only lower ligand incorporated by L. reuteri, it
appears to be incorporated less efficiently than the benzimid-
azoles in Sm cobTLr
+ (Table 2). Interestingly, both Sm cobTSe
+
and Sm cobTLr
+ were capable of producing [Ade]Cba 6 without
the exogenous addition of adenine, indicating that intracellular
adenine pools are available for use as lower ligands in Si. meliloti
as has previously been observed in Sa. enterica (Anderson et al.,
2008). This is illustrated in Figure 4A, where [Ade]Cba 6 was
detected in all corrinoid extracts from Sm cobTSe
+.
The two cobT homologs of V. parvula exhibited distinct lower
ligand incorporation profiles when expressed individually in
Si. meliloti. Whereas both Sm cobTVp
+ and Sm arsABVp
+ werelsevier Ltd All rights reserved
Figure 4. Guided Biosynthesis in Si. meliloti
bluB cobU Expressing cobT Homologs
HPLC analysis of corrinoids extracted from (A) Sm
cobTSe
+ and (B) Sm arsABVp
+ containing the indi-
cated lower ligand bases. The identities of the
numbered peaks were verified by LC-MS/MS.
Asterisks indicate the addition of 0.1 mM cobal-
amin 1 to cultures to support growth.
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Sm arsABVp
+ was the only strain that also incorporated the
phenolic substrates p-cresol and phenol (Figure 4B; Table 2).
Sm cobTVp
+ also incorporated adenine, although to a lesser
extent than either Sm cobTSe
+ or Sm cobTLr
+, even though
adenine incorporation was not observed in V. parvula (Table 1).
Together, these results indicate that the range of lower ligands
that can be incorporated into cobamides in a given organism is
heavily influenced by cobT.
Site-Directed Mutagenesis of Sa. enterica cobT Alters
Lower Ligand Attachment Specificity
The results presented above demonstrate that expression of
cobT homologs from different bacteria in Si. meliloti allowed it
to produce cobamides that wild-type Si. meliloti is incapable of
producing. This finding led us to investigate the sequence varia-
tions among cobT homologs that may contribute to the observed
differences in substrate specificity. A multiple sequence align-
ment of the CobT homologs revealed that the residues at posi-
tions equivalent to Ser80 and Gln88 in Sa. enterica CobT covary
with the ability to attach adenine (Figure 5A). CobT enzymes with
Ser andGlu at these positions allow the incorporation of adenine,
whereas those that do not incorporate adenine have Phe/Tyr/Trp
and Met, respectively (Figure 5A). These residues were previ-
ously implicated in the stabilization of adenine in the active site
of Sa. enterica CobT by interacting with the amino group (N10)
and the N3 ring nitrogen of adenine (Cheong et al., 2001).
To test the hypothesis that residues Ser80 and Gln88 of
Sa. enterica CobT influence the ability to activate adenine, we
performed site-directed mutagenesis on Sa. enterica cobT to
change these residues to Phe and Met, respectively, which
are found at equivalent positions in Si. meliloti CobU (Figure 5A).
Plasmids containing cobTSe with the S80F, Q88M, or S80F/
Q88M mutations were introduced into the Si. meliloti bluB
cobU strain. These strains were cultured in the presence of a
limiting amount of DMB to compare the level of attachment
of DMB and intracellular adenine. HPLC analysis of corrinoid
extracts from these cultures showed that Sm cobTSe
+ pro-
duced approximately equal amounts of [Ade]Cba 6 and cobal-
amin 1 under these conditions (Figure 5B). Sm cobTSe S80F
produced 2.7-fold less [Ade]Cba 6 than Sm cobTSe
+ but
produced a similar level of cobalamin 1, after normalizing forChemistry & Biology 20, 1265–1274, October 24, 2013 ªculture density (Figure 5B). The Q88M
mutation impacted both DMB and
adenine incorporation, because 2.4-fold
less [Ade]Cba 6 and 2.3-fold more
cobalamin 1 was produced by Sm
cobTSe Q88M compared to Sm cobTSe
+
(Figure 5B). The effects of the S80F andQ88M mutations appeared to be additive, as the Sm cobTSe
S80F/Q88M double mutant produced 3.5-fold less [Ade]Cba
6 and 2.6-fold more cobalamin than Sm cobTSe
+ (Figure 5B).
These results provide further evidence that differences in
cobT sequence are responsible for the observed differences
in lower ligand incorporation. The active site residues Ser and
Gln are not the sole determinants of adenine activation, how-
ever, because Si. meliloti strains expressing cobU genes with
the reciprocal mutations were unable to incorporate adenine
(data not shown).
Altered Lower Ligand Specificity Results in a Loss of
Viability in Si. meliloti
In the course of our experiments, we observed that the growth of
the Si. meliloti strains varied according to the lower ligand base
provided, and supplementation with cobalamin 1 was required
for growth when certain strains were supplied with adenine or
phenolic compounds (Figure 4). This result suggested that
some of the cobamides produced did not support growth in Si.
meliloti. To measure the effect of different cobamides on growth,
the OD600 of Sm cobTSe
+ cultures was measured following
growth to stationary phase in minimal media containing each
lower ligand base that could be incorporated into a cobamide.
We found that DMB, 5-methylbenzimidazole (MeBza), and benz-
imidazole (Bza) were equivalent in supporting the growth of Si.
meliloti, whereas cultures supplied with 5-methoxybenzimida-
zole (OMeBza), 5-hydroxybenzimidazole (OHBza), or adenine
reached a lower final culture density (Figure 6A). This result indi-
cates that cobalamin 1, [MeBza]Cba 2, and [Bza]Cba 4 support
the growth of Si. meliloti to a greater extent than [OMeBza]Cba 3,
[OHBza]Cba 5, or [Ade]Cba 6.
To verify that the phenotype observed when lower ligand
bases were added to cultures was due to the effect of the coba-
mides produced rather than differences in the efficiency of incor-
poration of the lower ligands, an Si. meliloti cobD bluB strain,
which is incapable of producing corrinoids or DMB, was cultured
in the presence of a representative purified cobamide from each
structural class. Cultures grown with [Ade]Cba 6 or [Cre]Cba 9
led to 3.7- and 13-fold lower final culture densities, respectively,
than those grown with cobalamin 1 (Figure 6B). These results
demonstrate that different cobamides are not functionally equiv-
alent in Si. meliloti.2013 Elsevier Ltd All rights reserved 1269
Table 2. Cobamides Produced by Guided Biosynthesis in Si. meliloti bluB cobU Expressing cobT Homologs
Lower Ligand Base Provideda
DMB MeBza OMeBza Bza OHBza Ade Phe Cre
Sm cobUSm
+ 100 100 2.0 27 4.3 0 0 0
Sm cobTDm
+ 64 14 40 33 0.61 0 0 0
Sm cobTSe
+ 96 38 22 40 NAb 56 0 0
Sm cobTLr
+ 100 76 59 75 NA 9.7c 0c 0c
Sm cobTVp
+ 63 94 100 100 41 1.0 0 0
Sm arsABVp
+ 42 4.6 11 30 3.9c 0c 1.0c 11c
aNumbers represent the level of incorporation of each lower ligand base as a percentage of the total corrinoids present.
bNA, not available. Percentage is not available due to coelution of [OHBza]Cba and [Ade]Cba.
cCultures were grown with cobalamin to achieve higher growth, but cobalamin present in the corrinoid extracts was not used in the calculations.
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It has historically been recognized that different prokaryotes pro-
duce a variety of different cobamides, and that the structural dif-
ferences among these cofactors are almost entirely limited to the
lower ligand (Brown et al., 1955; Ford et al., 1955). Although
diverse cobamides have been observed in environments such
as the human intestine, bovine rumen, and contaminated
groundwater, the microbes that produce cobamides have
been observed to synthesize only one or two different coba-
mides when grown in pure culture (Brown et al., 1955; Kra¨utler
et al., 1988; Stupperich et al., 1989, 1990; Keck and Renz,
2000; Allen and Stabler, 2008; Girard et al., 2009; Y. Men,
E.C.S., S. Yi, T.S.C., R.H. Allen, M.E.T., and L. Alvarez-Cohen,
unpublished data). This study addresses the molecular basis of
lower ligand selectivity in a representative set of bacteria. We
have identified the cobT gene as being responsible for limiting
the range of lower ligands that can be incorporated. Specificity
in CobT activity could be a mechanism of limiting the production
of cobamides to those that function as cofactors for a particular
organism.
Our genetic system in Si. meliloti allowed us to examine the in-
fluence of substrate specificity by CobT on cobamide synthesis
in the absence of factors that may be unique to each organism.
We found that the range of lower ligands that could be attached
by the Si. meliloti strains expressing cobT homologs mirrored
that of the originating bacteria in nearly all cases. The fact that
multiple lower ligand bases can be incorporated by guided
biosynthesis suggests that the structure of the cobamide pro-
duced by each organism is governed in part by the availability
of lower ligand bases in the cell. Additionally, our results show
that the range of lower ligands that can be incorporated is limited
by substrate specificity in cobT, and that cobT homologs from
different organisms have distinct specificity profiles. A notable
exception to this pattern was L. reuteri, which was incapable
of incorporating benzimidazoles by guided biosynthesis,
whereas expression of L. reuteri cobT enabled the incorporation
of benzimidazoles in Si. meliloti. It is possible that in L. reuteri
another enzyme, such as CobS, prevents the incorporation
of benzimidazoles into cobamides. This hypothesis could be
addressed experimentally by expressing the L. reuteri cobS
gene in a Si. meliloti cobS mutant.
Our results showed that the major differences in substrate
specificity among the cobT homologs are in the ability to activate1270 Chemistry & Biology 20, 1265–1274, October 24, 2013 ª2013 Eadenine and phenolic compounds, whereas the activation of
benzimidazoles is common to all of the cobT homologs tested.
Differences in the preferences of each CobT enzyme for each
lower ligand substrate are investigated in more detail in
the accompanying paper (Hazra et al., 2013) in this issue of
Chemistry & Biology. The activation of phenolic compounds
appears to be a specialized function of the arsA and arsB gene
products, because none of the other CobT homologs in this or
previous studies is capable of activating phenolic compounds
(Cheong et al., 2001, 2002; Chan and Escalante-Semerena,
2011). This is likely due to significant differences in the reactivity
required for the formation of an O-linked rather than an N-linked
glycosidic bond. In addition, consistent with previous studies of
Sp. ovata ArsAB, V. parvula and Sm arsABVp
+ can produce both
benzimidazolyl and phenolyl cobamides by guided biosynthesis
(Chan and Escalante-Semerena, 2011; Newmister et al., 2012).
Given that V. parvula naturally produces both [Cre]Cba 9 and
[Bza]Cba 4, and that Sm arsABVp
+ is capable of activating benz-
imidazoles in addition to phenolic compounds, it is puzzling that
V. parvula possesses an additional CobT homolog that activates
only benzimidazoles (and adenine, to a limited extent). A
possible explanation is that V. parvula cobT and arsAB are differ-
entially expressed in order to produce varying ratios of [Cre]Cba
9 and [Bza]Cba 4 under different environmental conditions.
We found that the ability to activate adenine for the production
of [Ade]Cba 6 in Si. meliloti is limited to only three of the cobT
homologs. In the case of Sa. enterica and L. reuteri, this is
consistent with their production of [Ade]Cba 6. Our observation
that Sm cobTVp
+ produces a small amount of [Ade]Cba 6 is
unexpected, considering the absence of [Ade]Cba 6 in the
V. parvula corrinoid extracts. This may be explained either by
an inability to detect low levels of [Ade]Cba 6 that may be present
in the V. parvula extract or an insufficient concentration of free
adenine in V. parvula. The production of a relatively low level of
[Ade]Cba 6 by Sm cobTVp
+ may be due to the presence of Tyr
and Gln in V. parvula CobT at positions equivalent to residues
S80 and Q88 in Sa. enterica CobT. Previously, it was proposed
that hydrophilic residues are important for stabilizing adenine
in the binding pocket and that the hydrophobic residues Y79
and M87 at analogous positions in Sp. ovata ArsA are important
for stabilizing phenolic lower ligand bases (Cheong et al., 2001;
Newmister et al., 2012). If additional CobT enzymes are found
that share this pattern, it may be possible to use this analysis
in the bioinformatic prediction of cobamide structures basedlsevier Ltd All rights reserved
Figure 5. Site-Directed Mutagenesis of Sa. enterica CobT Leads to
Altered Lower Ligand Incorporation
(A) Multiple sequence alignment of CobT homologs that are capable of acti-
vating adenine when expressed in Si. meliloti (Sa. enterica CobT, L. reuteri
CobT, and V. parvula CobT) and those that do not activate adenine (Si. meliloti
CobU, Dc. mccartyi CobT, and V. parvula ArsA). Only the region surrounding
the two amino acid residues targeted for site-directed mutagenesis (arrows) is
shown. ArsB is not included because it lacks a true active site (Newmister
et al., 2012).
(B) HPLC analysis of corrinoids extracted from Sm cobTSe
+ (WT), Sm cobTSe
S80F, Sm cobTSe Q88M, and Sm cobTSe S80F/Q88M cultures grown in the
presence of 0.5 mM DMB. The ratio of [Ade]Cba 6 to cobalamin 1 is shown in
parentheses.
See also Figure S2.
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several CobT homologs reveals a co-occurrence of aromatic
residues (Phe/Tyr/Trp) with Met, or H-bonding residues (Ser/
Thr/Cys) with Gln or Val (Figure S2B).
We speculate that the ability to exclude certain lower ligand
bases from incorporation into cobamides is a mechanism of pre-
venting an organism from producing a cobamide that it cannot
use. Based on this hypothesis, specificity in cobT would be
particularly important for the exclusion of adenine, which is pre-
sent intracellularly but is used as a lower ligand only by a subset
of bacteria. This idea is supported by our observation that the
production of [Ade]Cba 6 in Sm cobTSe
+ leads to poor growth
(Figure 6A). A counterexample to this case is Sp. ovata, which
can incorporate benzimidazoles as cobamide lower ligands but
is incapable of using benzimidazolyl cobamides for the meta-
bolism of certain carbon sources (Stupperich et al., 1990; Mok
and Taga, 2013). The absence of a mechanism of excluding
benzimidazoles from incorporation into cobamides in Sp. ovataChemistry & Biology 20, 1265–1suggests that Sp. ovata does not produce benzimidazoles or
encounter them in the environment.
The results of this study suggest that diversity in cobamide
structure is achieved in nature by a combination of the biosyn-
thesis or availability of various lower ligand bases and themolec-
ular specificity in the lower ligand activation gene cobT. Because
the structure of cobamides has been shown to affect cofactor
function in many cases, specificity in cobT likely ensures that
bacteria produceonly cobamides that canbeused for theirmeta-
bolic processes.However, the reasonwhysuchdiversity in coba-
mide structure exists in nature remains unclear. The use of lower
ligand bases that also function in other cellular processes, such
as purines, or are products of amino acid catabolism, such as
phenolic compounds, is relatively common among bacteria
(Stupperich and Eisinger, 1989; Anderson et al., 2008). It is there-
fore puzzling that somebacteria havededicated pathways for the
biosynthesis of benzimidazoles that, to the best of our knowl-
edge, only function as cobamide lower ligands. Substrate spec-
ificity in CobT could be explained by the requirement of certain
metabolic processes for specific cobamides (Yan et al., 2012,
2013; Yi et al., 2012; Mok and Taga, 2013). In addition, diversity
in cobamide structure may be driven by a need for cobamide-
producing organisms to limit the cobamide remodeling or
salvaging activity of other organisms. Further biochemical and
ecological studieswill be necessary to explore thesepossibilities.
SIGNIFICANCE
Cobamides, which include vitamin B12, are essential cofac-
tors for many organisms, both eukaryotes and prokaryotes,
in a variety of metabolic pathways, but are produced only by
a subset of prokaryotes. Cobamides are distinguished by
the structure of the lower ligand, and different cobamides
are not necessarily functionally equivalent as cofactors.
Although 16 structurally distinct cobamides have been
described, organisms typically synthesize only one or two
different cobamides when grown in pure culture. Here, we
sought to identify the molecular factors that determine
which cobamides are produced by bacteria. The final steps
in cobamide biosynthesis involve activation of a lower ligand
base and attachment to a cobamide precursor. We utilized
guided biosynthesis assays in four bacteria and found that
a distinct set of lower ligand bases is incorporated by each
organism. Heterologous expression of cobT homologs
from these bacteria and from Dehalococcoides mccartyi in
Sinorhizobium meliloti demonstrated that CobT is respon-
sible for preventing the incorporation of certain lower ligand
bases. Additionally, the Salmonella enterica cobT gene was
engineered by site-directed mutagenesis to lower its affinity
for adenine relative to 5,6-dimethylbenzimidazole, the lower
ligand of vitamin B12. We also report on the potential for pre-
diction of the cobamide biosynthetic capability of microbial
communities based on metagenomic analysis of cobT
homologs. Our results show that both the availability of
lower ligand bases and the substrate specificity of CobT
limit the lower ligands that can be attached to form coba-
mides. Finally, we found that growth is inhibited inSi.meliloti
strains that have been engineered to synthesize alternate
cobamides. Our results suggest that substrate specificity274, October 24, 2013 ª2013 Elsevier Ltd All rights reserved 1271
Figure 6. Biosynthesis of Nonnative Corri-
noids Affects Growth of Si. meliloti
The OD600 of Si. meliloti cultures following growth
to stationary phase was measured for (A) Sm
cobTSe
+ cultures containing 5 mM indicated com-
pounds and (B) Si. meliloti cobD bluB cultures
containing 1 mM indicated purified cobamides.
Error bars represent the standard error of three
samples.
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do not support their metabolism. It is important to under-
stand the molecular determinants that underlie cobamide
structural diversity due to the integral role played by coba-
mides in several important microbial communities.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
Si. meliloti strains were grown at 30Cwith aeration on LB agar plates contain-
ing 2.5 mMMgSO4 and 2.5 mM CaCl2 (LBMC) or in M9 sucrose medium con-
taining 10 mg/l biotin, 10 mM cobalt chloride, and 1 mg/ml methionine (Maniatis
et al., 1982). When necessary, media were supplemented with antibiotics as
follows: 10 mg/ml tetracycline; 100 mg/ml spectinomycin; 50 mg/ml gentamicin;
and 500 mg/ml streptomycin. Cobalamin auxotrophs of Si. meliloti were
cultured with 10 mM cyanocobalamin when needed. For extraction of corri-
noids from Si. meliloti, 5 ml of M9 was inoculated with a colony of Si. meliloti
grown on LBMC and incubated for 40–50 hr. These cultures were diluted to
an OD600 of 0.02–0.04 in 250 ml M9 and incubated for 48–60 hr.
For extraction of native corrinoids from Sa. enterica serovar Typhimurium
strain LT2, a 500 ml culture was grown anaerobically under an N2 atmosphere
in a minimal medium with ethanolamine as a nitrogen source (Keck and Renz,
2000). For guided biosynthesis experiments, Sa. enterica cultures were grown
aerobically in NCE medium supplemented with 1 mM dicyanocobinamide and
the indicated lower ligand bases with 1,2-propanediol as the carbon source
(Gray and Escalante-Semerena, 2009). L. reuteri DSM 20016 was cultured
anaerobically in vitamin B12-free assay medium (Difco) at 37
C under an atmo-
sphere of 95% N2 and 5% CO2 at pH 6.3. V. parvula DSM 2008 was cultured
anaerobically in a modified Veillonellamedium at 37C under 95% N2 and 5%
CO2 at pH 7.0 in which 1.5 g/l casamino acids were substituted for individual
amino acids (Lopes and Cruz, 1976). For all guided biosynthesis experiments,
the media were supplemented with 5 mM lower ligand base unless otherwise
noted. OD600 measurements were recorded using a BioTek Synergy 2
multiwell plate reader. Corrinoids were purified for feeding experiments from
cultures of Sa. enterica or Sp. ovata and quantified as described (Gray and
Escalante-Semerena, 2009; Yi et al., 2012).
To determine the ability of DMB to enter L. reuteri cells, three 10 ml cultures
of anaerobic MRS medium containing 5 mmol DMB were inoculated with
L. reuteri to an OD600 of 0.03. Following 24 hr of growth, cells were harvested
by centrifugation at 9,0003 g and washed in 1 ml of 0.85% saline, and the cell
pellet was resuspended in 1ml methanol. The lysate was applied to a Sep-Pak
C18 cartridge (Waters), and the cartridge was washed with 6 ml of 20%
methanol and eluted with 2 ml of 80% methanol. The extract was dried under
vacuum and resuspended in 0.25 ml deionized H2O. The DMB in the extract
was quantified by HPLC as described below.
Genetic and Molecular Techniques
To construct theSi. meliloti cobU::SpcR strain, a 1.3 kb genomic fragment con-
taining the Si. meliloti cobU gene and flanking region was amplified by PCR1272 Chemistry & Biology 20, 1265–1274, October 24, 2013 ª2013 Elsevier Ltd All rights resand cloned into pUC19 (Yanisch-Perron et al.,
1985) at the EcoRI and PstI restriction sites. An
SpcR fragment obtained by BamHI digestion of
pHP45U (Fellay et al., 1987) was cloned into a
BglII site located within the cobU open reading
frame (ORF). The EcoRI-PstI fragment containingcobU::SpcR was transferred to the suicide plasmid pK19 mob sacB (Scha¨fer
et al., 1994). The resulting plasmid was introduced onto the Si. meliloti
chromosome by triparental mating (Leigh et al., 1985). Screening for the
cobU gene replacement and loss of the pK19 mob sacB plasmid were per-
formed as described (Scha¨fer et al., 1994; Taga and Walker, 2010). Double
mutant strains were constructed by M12 phage transduction (Finan et al.,
1984).
For expression of cobT homologs inSi. meliloti, theSa. enterica trp promoter
sequence was introduced at the BglII and EcoRI restriction sites in the vector
pMP220 to produce pMP220+Ptrp. To construct plasmids expressing cobT
homologs from Si. meliloti, Sa. enterica, and Dc. mccartyi, genomic regions
including the cobT ORF and 20 bp of upstream sequence were amplified by
PCR from purified genomic DNA (Chen and Kuo, 1993) and cloned into
pMP220+Ptrp at the XbaI and PstI restriction sites. To avoid potential codon
usage incompatibility, the L. reuteri cobT ORF was synthesized (GeneArt) to
contain codons optimized for expression in Si. meliloti (Puigbo` et al., 2007,
2008) and fused with the 25 bp sequence directly upstream of the Si. meliloti
cobU ORF (Figure S3) and cloned into pMP220+Ptrp. A genomic sequence
spanning the V. parvula arsA and arsB ORFs and 20 bp upstream of
arsA was amplified by PCR from the V. parvula genome and cloned into
pMP220+Ptrp. The Sa. enterica cobT S80F and Q88M mutations were con-
structed by PCR-mediated site-directed mutagenesis (Weiner et al., 1994).
All plasmids were introduced into Si. meliloti cobU::SpcR bluB::gus GmR by
triparental mating (Leigh et al., 1985).
Phylogenetic Analysis of CobT Sequences
CobT sequences were downloaded from PFAM (Chen et al., 2011) and edited
using BioEdit (Hall, 1999). The phylogenetic tree was obtained from CIPRES
(Stamatakis, 2006; Stamatakis et al., 2008; Miller et al., 2010) and visualized
usingMEGA5 (Tamura et al., 2011). Alignments were prepared usingMUSCLE
(Edgar, 2004). The identity matrix was constructed using BioEdit (Hall, 1999).
More detailed methods may be found in Supplemental Experimental
Procedures.
Corrinoid Extraction and Analysis
Corrinoids were extracted from cell pellets essentially as described (Yi et al.,
2012). Briefly, cell pellets were resuspended in methanol with 0.1% potassium
cyanide. Following cell lysis, clarification, and removal of solvent, the extract
was applied to a Sep-Pak C18 cartridge (Waters) and eluted in 1.8 ml of 75%
methanol. The sample was dried at 45C under reduced pressure, resus-
pended in 0.5 ml distilled water, and filtered through a 10,000 MWCO filter
(Pall). Samples were stored at 20C prior to analysis.
An Agilent 1200 series HPLC system equipped with a UV-diode array detec-
tor was used to analyze the extracted corrinoids. Samples were injected onto
an Agilent SB-Aq 4.5 3 150 mm column with 5 mm pore size at a flow rate of
1 ml/min with mobile phases of A, 0.1% formic acid in water, and B, 0.1%
formic acid in methanol. The column was maintained at 30C. Corrinoids
were eluted with a gradient of 25% solvent B for 2 min, 25%–34% solvent B
over 11 min, and 34%–70% solvent B over 3.5 min. LC-MS/MS analysis
was performed using the above LC method on an Agilent 6410 liquiderved
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Genetic Basis for Variation of Cobamide Structurechromatograph-triple quadrupole mass spectrometer with multiple reaction
monitoring (Yi et al., 2012).
Synthesis and Purification of 5-Hydroxybenzimidazole
OHBza was synthesized from OMeBza as previously described (Renz et al.,
1993) with some modifications and purified (see Supplemental Experimental
Procedures).
ACCESSION NUMBERS
The GenBank accession numbers for the V. parvula arsA and arsB sequences
are KF615856 and KF615857, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2013.08.006.
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